关于体重管理参与的EMBER试验:一种混合型1型随机对照试验协议
Jessica Y Breland1, Terri L Fletcher2, Shira Maguen3
1VA HSR&D Center for Innovation to Implementation, VA Palo Alto Health Care System and Michael E DeBakey VA Medical Center, 795 Willow Road (MPD-152), Menlo Park, CA 94025, USA.
Contemporary clinical trials
|October 26, 2023
概括
一个名为EMBER (Enhancing Motivation for Better Engagement and Reach) 的新工具旨在促进退伍军人参与体重管理计划. 本研究测试EMBER是否增加了对现有的VHA重量管理服务的参与.
科学领域:
- 医疗保健服务研究 医疗服务研究
- 行为科学 行为科学
- 实施科学 实施科学
背景情况:
- 肥胖影响了近40%的退伍军人卫生管理局 (VHA) 用户.
- 虽然VHA的减肥计划取得了成功,但只有不到8%的符合条件的用户参与.
- 低参与度阻碍了VHA国家体重管理倡议的有效性.
研究的目的:
- 评估基于激励面试的新型工具EMBER在增加对VHA体重管理计划的参与方面的有效性.
- 评估EMBER在提高体重管理服务的动机和覆盖范围方面的潜力.
- 确定自助工具是否可以弥合程序可用性和利用率之间的差距.
主要方法:
- 一个随机的混合型1有效性实施试验,涉及肥胖的VHA用户.
- 参与者 (N=470) 被随机分配到接受EMBER工具或仅信息控制.
- 测量结果包括两个月后的体重管理参与,六个月后的保持,行为变化和生活质量.
主要成果:
- 主要结果是干预后两个月任何体重管理参与的可能性.
- 二次结果包括持续的参与,行为修改,减肥和改善生活质量.
- 实施结果,如覆盖范围和适当性也将被评估.
结论:
- EMBER是第一个自我指导的,动机面试干预,旨在提高体重管理计划的参与度.
- 这项研究采用一种低接触,人口健康策略,可适应其他健康计划.
- 混合型1型设计可促进发现的可扩展和可持续实施.
相关概念视频
01:11Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
01:16Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K
01:11Blinding
2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K
01:12Hazard Ratio
137
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
137